Annual report pursuant to Section 13 and 15(d)

Disclosure of Prior Period Financial Statement Immaterial Errors (Share Issuance) (Details)

v3.21.2
Disclosure of Prior Period Financial Statement Immaterial Errors (Share Issuance) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Revised Consolidated Balance Sheets [Abstract]      
Subscription receivable   $ 5,549  
Total current assets $ 104,597 61,748  
Total assets 146,968 94,189  
Total equity 108,568 56,607 $ 2,457
Total liabilities and stockholders’ equity $ 146,968 $ 94,189  
Revised Consolidated Statement of Operations [Abstract]      
Loss per common share attributable to iBio, Inc. stockholders - basic and diluted $ (0.12) $ (0.61)  
Weighted-average common shares outstanding - basic and diluted 195,620 62,795  
Related to the Omission of a Share Issuance [Member]      
Revised Consolidated Balance Sheets [Abstract]      
Subscription receivable   $ 2,190  
Total current assets   63,938  
Total assets   96,379  
APIC   209,121  
Total equity   58,797  
Total liabilities and stockholders’ equity   $ 96,379  
Revised Consolidated Statement of Operations [Abstract]      
Loss per common share attributable to iBio, Inc. stockholders - basic and diluted   $ (0.61)  
Weighted-average common shares outstanding - basic and diluted   62,891  
As Reported [Member] | Related to the Omission of a Share Issuance [Member]      
Revised Consolidated Balance Sheets [Abstract]      
Total current assets   $ 61,748  
Total assets   94,189  
APIC   206,931  
Total equity   56,607  
Total liabilities and stockholders’ equity   $ 94,189  
Revised Consolidated Statement of Operations [Abstract]      
Loss per common share attributable to iBio, Inc. stockholders - basic and diluted   $ (0.61)  
Weighted-average common shares outstanding - basic and diluted   62,795  
Error Correction, Adjustment [Member] | Related to the Omission of a Share Issuance [Member]      
Revised Consolidated Balance Sheets [Abstract]      
Subscription receivable   $ 2,190  
Total current assets   2,190  
Total assets   2,190  
APIC   2,190  
Total equity   2,190  
Total liabilities and stockholders’ equity   $ 2,190  
Revised Consolidated Statement of Operations [Abstract]      
Loss per common share attributable to iBio, Inc. stockholders - basic and diluted   $ 0.00  
Weighted-average common shares outstanding - basic and diluted   96